Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration
R Prince Davis, Amy C Schefler, Timothy G MurrayBascom Palmer Eye Institute, Department of Ophthalmology, University of Miami Miller School of Medicine, Miami, FL, USAPurpose: To report the outcomes of same-day, bilateral intravitreal anti-vascular endothelial growth factor (VEGF) therapy for a cons...
Guardado en:
Autores principales: | R Prince Davis, Amy C Schefler, Timothy G Murray |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eac41589b1624535b0700a01d797e540 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Choriocapillaris Vascular Density Changes: Healthy vs. Advanced Exudative Age-Related Macular Degeneration Previously Treated with Multiple Anti-VEGF Intravitreal Injections
por: Maria Cristina Savastano, et al.
Publicado: (2021) -
Use of nepafenac (Nevanac®) in combination with intravitreal anti-VEGF agents in the treatment of recalcitrant exudative macular degeneration requiring monthly injections
por: Eric Chen, et al.
Publicado: (2010) -
The effect of vitreomacular adhesion in exudative age-related macular degeneration on the results of ranibizumab intravitreal injection
por: Suzuki H, et al.
Publicado: (2017) -
Intravitreal injection of aflibercept, an anti-VEGF antagonist, down-regulates plasma von Willebrand factor in patients with age-related macular degeneration
por: Mariko Yamashita, et al.
Publicado: (2018) -
Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone
por: José Mª Ruiz-Moreno, et al.
Publicado: (2008)